MoneyWorks4Me

The sales slipped to Rs. 130.83 millions for the September 2023 quarter as against Rs. 185.47 millions during the year-ago period.The company suffered a huge decline of -81.83% to Rs. 1.93  millions from Rs. 10.62 millions  of corresponding previous quarter.A decline of 16.81 millions was observed in the OP in the quarter ended September 2023 from 31.05 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 130.83 185.47 -29.46 281.96 364.81 -22.71 661.71 694.30 -4.69
Other Income 1.71 0.95 80.00 1.99 1.11 79.28 5.11 5.92 -13.68
PBIDT 16.81 31.05 -45.86 41.62 59.77 -30.37 92.87 90.07 3.11
Interest 5.19 7.17 -27.62 11.28 12.91 -12.63 23.82 20.66 15.30
PBDT 11.62 23.88 -51.34 30.34 46.86 -35.25 69.05 69.41 -0.52
Depreciation 9.04 9.73 -7.09 17.84 19.36 -7.85 39.17 35.48 10.40
PBT 2.58 14.15 -81.77 12.50 27.50 -54.55 29.88 33.93 -11.94
TAX 0.65 3.53 -81.59 3.13 6.87 -54.44 7.47 7.50 -0.40
Deferred Tax 0.47 0.47 0.00 0.88 0.88 0.00 1.97 3.05 -35.41
PAT 1.93 10.62 -81.83 9.37 20.63 -54.58 22.41 26.43 -15.21
Equity 54.85 54.85 0.00 54.85 54.85 0.00 54.85 54.85 0.00
PBIDTM(%) 12.85 16.74 -23.25 14.76 16.38 -9.91 14.03 12.97 8.19
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..